Stark H - Search Results

1

Diether (substituted) piperidine derivatives as novel, histamine H3 receptor ligands.

Kuder KJ, Ligneau X, Camelin JC, Lazewska D, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K. Kuder KJ, et al. Among authors: stark h. Inflamm Res. 2009 Apr;58 Suppl 1:47-8. doi: 10.1007/s00011-009-2002-6. Inflamm Res. 2009. PMID: 19266264 No abstract available.

2

The histamine H3-receptor: pharmacology, roles and clinical implications studied with agonists.

Arrang JM, Garbarg M, Schwartz JC, Lipp R, Stark H, Schunack W, Lecomte JM. Arrang JM, et al. Among authors: stark h. Agents Actions Suppl. 1991;33:55-67. doi: 10.1007/978-3-0348-7309-3_3. Agents Actions Suppl. 1991. PMID: 1647132 Review.

3

Synthesis, X-ray crystallography, and pharmacokinetics of novel azomethine prodrugs of (R)-alpha-methylhistamine: highly potent and selective histamine H3 receptor agonists.

Krause M, Rouleau A, Stark H, Luger P, Lipp R, Garbarg M, Schwart JC, Schunack W. Krause M, et al. Among authors: stark h. J Med Chem. 1995 Sep 29;38(20):4070-9. doi: 10.1021/jm00020a022. J Med Chem. 1995. PMID: 7562942

4

Azines and diazines as potential histamine H3-receptor antagonists.

Kieć-Kononowicz K, Ligneau X, Stark H, Schwartz JC, Schunack W. Kieć-Kononowicz K, et al. Among authors: stark h. Arch Pharm (Weinheim). 1995 May;328(5):445-50. doi: 10.1002/ardp.19953280509. Arch Pharm (Weinheim). 1995. PMID: 7611840

5

Design of histamine H3-receptor agonists and antagonists.

Schunack W, Stark H. Schunack W, et al. Among authors: stark h. Eur J Drug Metab Pharmacokinet. 1994 Jul-Sep;19(3):173-8. doi: 10.1007/BF03188918. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7867658 Review.

6

Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models.

Schlicker E, Kathmann M, Reidemeister S, Stark H, Schunack W. Schlicker E, et al. Among authors: stark h. Br J Pharmacol. 1994 Aug;112(4):1043-8. doi: 10.1111/j.1476-5381.1994.tb13188.x. Br J Pharmacol. 1994. PMID: 7952862 Free PMC article.

7

[125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.

Ligneau X, Garbarg M, Vizuete ML, Diaz J, Purand K, Stark H, Schunack W, Schwartz JC. Ligneau X, et al. Among authors: stark h. J Pharmacol Exp Ther. 1994 Oct;271(1):452-9. J Pharmacol Exp Ther. 1994. PMID: 7965746

8

[125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor.

Stark H, Purand K, Hüls A, Ligneau X, Garbarg M, Schwartz JC, Schunack W. Stark H, et al. J Med Chem. 1996 Mar 15;39(6):1220-6. doi: 10.1021/jm9504767. J Med Chem. 1996. PMID: 8632428

9

New potent azomethine prodrugs of the histamine H3-receptor agonist (R)-alpha-methylhistamine containing a heteroarylphenyl partial structure.

Krause M, Rouleau A, Stark H, Luger P, Garbarg M, Schwartz JC, Schunack W. Krause M, et al. Among authors: stark h. Arch Pharm (Weinheim). 1996 Apr;329(4):209-15. doi: 10.1002/ardp.19963290407. Arch Pharm (Weinheim). 1996. PMID: 8669985

10

Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity.

Stark H, Purand K, Ligneau X, Rouleau A, Arrang JM, Garbarg M, Schwartz JC, Schunack W. Stark H, et al. J Med Chem. 1996 Mar 1;39(5):1157-63. doi: 10.1021/jm9507688. J Med Chem. 1996. PMID: 8676353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,195 results

Search Page

Filters